摘要:
The present invention describes a reduction type coenzyme Q10 powder, a composition thereof, and a preparation method thereof. The reduction type coenzyme Q10 powder is obtained by reacting an oxidation type coenzyme Q10 with the presence of a reducing agent, removing an organic solvent and other purities after the reaction is finished to obtain an oil-soluble reduction type coenzyme Q10 liquid, and then directly performing prill formation with cold wind on an obtained reduction type coenzyme Q10 greasy substance. The reduction type coenzyme Q10 powder has a lower crystallinity, and in a Cu-Kα X-ray diffraction spectrum, has a strong peak at a diffraction angle 2θ being 18.9 DEG , and has a very strong absorption peak at a diffraction angle 2θ being 22.8 DEG. The reduction type coenzyme Q10 powder is in an incompletely crystallized state, has desirable stability and desirable oral bioavailability.
摘要:
The present invention provides 2, 6-dinitrogen-containing substituted purine compounds of formula (A) or salts or solvates thereof or the solvates of salts thereof, as well as pharmaceutical compositions containing such compounds. The compounds of the present invention have the characteristics of lower toxicity, broad anticancer spectrum, higher anticancer activity, good stability and the like. The compounds are useful for the manufacture of an antitumor medicament. The present invention also provides a process for preparing these compounds.